LIRILUMAB

UNII: S9XDI9W918
Preferred Substance Name: LIRILUMAB

1000676-41-4
ANTI-KIR ANTIBODY
BMS-986015
BMS-98601501
BMS-986015-01
IMMUNOGLOBULIN G4, ANTI-(HUMAN ANTIGEN RECEPTOR KIR (KILLER CELL IMMUNOGLOBULIN-LIKE)) (HUMAN MONOCLONAL ANTI-KIR(CHO) HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ANTI-KIR(CHO) LIGHT CHAIN, DIMER
IPH2102
IPH-2102
LIRILUMAB [INN]
LIRILUMAB [USAN]
LIRILUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

LIRILUMAB

Synonyms and Mappings

Resources

Note